|
In Vitro Culture of Dendritic Cells and Activation of Peripheral Mononuclear Cells in Patients with Chronic Myelogenous Leukemia |
| |
|
Honoraria - Cerulean Pharma; Insys Therapeutics; Novocure; Pharmacyclics; Taiho Pharmaceutical |
Consulting or Advisory Role - Cerulean Pharma; Insys Therapeutics; Novocure; Pharmacyclics |
Research Funding - Abbvie (Inst); Berg Pharma (Inst); Boston Biomedical (Inst); Celgene (Inst); Merck/Schering Plough (Inst); Merrimack (Inst); Superlab Far East (Inst) |
| |
|
Honoraria - Amgen; Bayer; Bristol-Myers Squibb; Celgene; Halozyme; Ipsen; Merrimack; Novartis; Roche; Sanofi |
Consulting or Advisory Role - Celgene; Gilead Sciences; Halozyme; Ipsen; Merrimack; novartis |
Speakers' Bureau - amgen; Bayer; Celgene; roche; sanofi |
Research Funding - Bayer (Inst); Genentech (Inst); Immunomedics (Inst); incyte (Inst); Karyopharm Therapeutics (Inst); Merck (Inst); Momenta Pharmaceuticals (Inst); novartis (Inst); Plexxikon (Inst); Regeneron (Inst); Taiho Pharmaceutical (Inst) |
Other Relationship - Celgene; emd serono; Halozyme; Roche; sanofi |
| |
|
Consulting or Advisory Role - Aduro Biotech; Halozyme |
Research Funding - Halozyme (Inst) |
| |
|
Consulting or Advisory Role - Celgene; LEK; Sirtex Medical |
Travel, Accommodations, Expenses - Lilly |
| |
|
No Relationships to Disclose |
| |
Jaykumar Ranchodbhai Thumar |
No Relationships to Disclose |
| |
|
Consulting or Advisory Role - Celgene; Genentech/Roche; Novocure; Pfizer |
Research Funding - Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Ignyta (Inst); Incyte (Inst); Newlink Genetics (Inst); PRISM Pharma (Inst); Stemline Therapeutics (Inst) |
Travel, Accommodations, Expenses - Celgene; Genentech/Roche |
| |
|
Employment - Benchling (I) |
Stock and Other Ownership Interests - Benchling (I) |
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Endocyte; GE Healthcare; Merck; Merrimack; Personal Genome Diagnostics; Siemens Healthcare Diagnostics; Taiho Pharmaceutical |
Speakers' Bureau - GE Healthcare |
Research Funding - Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Caris Life Sciences; Eisai; H3 Biomedicine; Inovio Pharmaceuticals; Karyopharm Therapeutics; Merrimack; Novartis; OncoMed; Plexxikon; Taiho Pharmaceutical |
Travel, Accommodations, Expenses - Caris Life Sciences; Endocyte; GE Healthcare; Merrimack |
| |
|
Consulting or Advisory Role - AstraZeneca; Novartis |
Speakers' Bureau - Merck; Novartis |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
|
Employment - Chan Soon-Shiong Institute for Advanced Health |
Consulting or Advisory Role - Bayer |
Speakers' Bureau - Bayer; Ipsen |
| |
|
No Relationships to Disclose |
| |
|
Consulting or Advisory Role - Amgen; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Genentech; Sirtex Medical |